Market Overview:
The global point of care (POC) diagnostic devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for POC diagnostics due to the rising incidence of infectious diseases and other lifestyle-related disorders, technological advancements in POC diagnostics devices, and growing preference for minimally invasive procedures. Based on type, the global POC diagnostic devices market is segmented into miniaturization and microfluidics technology, molecular diagnostics, non-invasive technology, and others. Miniaturization and microfluidics technology held the largest share of the global POC diagnostic devices market in 2017 owing to its advantages such as small size, low power consumption, portability, ease of use etc. Molecular diagnostics is expected to be one of the fastest-growing segments during the forecast period due its ability detect genetic variations that cause diseases. Based on application, patient self-testing held a major share of the global POC diagnostic devices market in 2017 followed by clinics & hospitals segment.
 Diagnostic Devices Industry Outlook.svg)
Product Definition:
Point of care (POC) diagnostic devices are medical devices used to provide rapid diagnosis of diseases or conditions, typically at the site where the patient is located. POC diagnostics offer many advantages over traditional laboratory-based tests, including speed, convenience, and lower cost. They are also well-suited for use in developing countries and other resource-limited settings.
Miniaturization and Microfluidics Technology:
Point of care diagnostic devices are used in healthcare facilities to diagnose and treat patients at the bedside. These devices have gained popularity due to their ease-of-use, portability, and cost effectiveness. The global point of care diagnostic device market was valued over USD 5 billion in 2015 owing to technological advancements coupled with increasing demand for home healthcare services.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze genetic material (DNA, RNA) in biological samples. It is an important aspect of medical science as it helps in the detection and diagnosis of various diseases at the early stages. These tests also help detect infectious agents such as viruses, bacteria & parasites, which may cause disease outbreaks.
Application Insights:
The patient self-testing segment dominated the global market in 2017. The growing prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes mellitus, and autoimmune disorders is expected to drive the demand for point of care diagnostics over the forecast period. Moreover, rising awareness about early diagnosis and adoption of point of care testing among healthcare providers is further anticipated to fuel growth during the study period.
Hospitals were estimated as the largest application segment in 2017 owing to increasing investments by manufacturers for R&D on molecular diagnostic devices and other advanced technologies that can help diagnose a disease at its initial stages before any symptoms appear. For instance, Thermodoctor from Biodesix Solutions provides real-time thermal analysis for detecting infectious microorganisms using only one sample with no additional blood or tissue samples required.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced POC diagnostic devices, and increasing healthcare expenditure in this region. Moreover, favorable government initiatives such as “10x Initiative†by the U.S.
In Asia Pacific, miniaturization and microfluidics technology-based point-of-care diagnostics devices are anticipated to witness lucrative growth over the forecast period owing to factors such as low cost compared with conventional methods used for diagnosis at a primary care center or hospital laboratory; ease in storage; portability; availability at retail stores; rapid results delivery time (hours instead of days); ability for self-testing by patients (instead of having a doctor come out).
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and heart diseases is expected to drive the demand for point of care diagnostic devices.
- Rising geriatric population is also anticipated to fuel the growth of this market as they are more susceptible to lifestyle diseases.
- Growing demand for home-based healthcare is another major factor that would propel the growth of POC diagnostic devices market in coming years.
- Technological advancements in POC diagnostics devices are likely to create new opportunities for this market in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Point of Care (POC) Diagnostic Devices Market Research Report
By Type
Miniaturization and Microfluidics Technology, Molecular Diagnostics, Non-Invasive Technology, Others
By Application
Patient Self-Testing, Clinics, Hospitals, Laboratories, Others
By Companies
Roche Diagnostics, Abaxis, Abbott POC, Alere Inc, Beckman Coulter, Beckton & Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Point of Care (POC) Diagnostic Devices Market Report Segments:
The global Point of Care (POC) Diagnostic Devices market is segmented on the basis of:
Types
Miniaturization and Microfluidics Technology, Molecular Diagnostics, Non-Invasive Technology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Patient Self-Testing, Clinics, Hospitals, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Diagnostics
- Abaxis
- Abbott POC
- Alere Inc
- Beckman Coulter
- Beckton & Dickinson
- Bayer Diabetes Care
- Hemocue AB
- International Technidyne Corporation
- LifeScan Inc
- Nipro Diagnostics
- Orasure Technologies
- PointCare Technologies
- Siemens HealthCare Diagnostics
 Diagnostic Devices Market Overview.svg)
Highlights of The Point of Care (POC) Diagnostic Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Miniaturization and Microfluidics Technology
- Molecular Diagnostics
- Non-Invasive Technology
- Others
- By Application:
- Patient Self-Testing
- Clinics
- Hospitals
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point of Care (POC) Diagnostic Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Diagnostic Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point of care diagnostic devices are medical devices that can be used by clinicians in the field to diagnose and monitor patients. These devices include blood pressure cuffs, heart rate monitors, and glucose meters.
Some of the key players operating in the point of care (poc) diagnostic devices market are Roche Diagnostics, Abaxis, Abbott POC, Alere Inc, Beckman Coulter, Beckton & Dickinson, Bayer Diabetes Care, Hemocue AB, International Technidyne Corporation, LifeScan Inc, Nipro Diagnostics, Orasure Technologies, PointCare Technologies, Siemens HealthCare Diagnostics.
The point of care (poc) diagnostic devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point of Care (POC) Diagnostic Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point of Care (POC) Diagnostic Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point of Care (POC) Diagnostic Devices Market - Supply Chain
4.5. Global Point of Care (POC) Diagnostic Devices Market Forecast
4.5.1. Point of Care (POC) Diagnostic Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point of Care (POC) Diagnostic Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Point of Care (POC) Diagnostic Devices Market Absolute $ Opportunity
5. Global Point of Care (POC) Diagnostic Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
5.3.1. Miniaturization and Microfluidics Technology
5.3.2. Molecular Diagnostics
5.3.3. Non-Invasive Technology
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Point of Care (POC) Diagnostic Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
6.3.1. Patient Self-Testing
6.3.2. Clinics
6.3.3. Hospitals
6.3.4. Laboratories
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Point of Care (POC) Diagnostic Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Point of Care (POC) Diagnostic Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Point of Care (POC) Diagnostic Devices Demand Share Forecast, 2019-2026
9. North America Point of Care (POC) Diagnostic Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
9.4.1. Patient Self-Testing
9.4.2. Clinics
9.4.3. Hospitals
9.4.4. Laboratories
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
9.7.1. Miniaturization and Microfluidics Technology
9.7.2. Molecular Diagnostics
9.7.3. Non-Invasive Technology
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Point of Care (POC) Diagnostic Devices Demand Share Forecast, 2019-2026
10. Latin America Point of Care (POC) Diagnostic Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
10.4.1. Patient Self-Testing
10.4.2. Clinics
10.4.3. Hospitals
10.4.4. Laboratories
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
10.7.1. Miniaturization and Microfluidics Technology
10.7.2. Molecular Diagnostics
10.7.3. Non-Invasive Technology
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Point of Care (POC) Diagnostic Devices Demand Share Forecast, 2019-2026
11. Europe Point of Care (POC) Diagnostic Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
11.4.1. Patient Self-Testing
11.4.2. Clinics
11.4.3. Hospitals
11.4.4. Laboratories
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
11.7.1. Miniaturization and Microfluidics Technology
11.7.2. Molecular Diagnostics
11.7.3. Non-Invasive Technology
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Point of Care (POC) Diagnostic Devices Demand Share, 2019-2026
12. Asia Pacific Point of Care (POC) Diagnostic Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
12.4.1. Patient Self-Testing
12.4.2. Clinics
12.4.3. Hospitals
12.4.4. Laboratories
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
12.7.1. Miniaturization and Microfluidics Technology
12.7.2. Molecular Diagnostics
12.7.3. Non-Invasive Technology
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Point of Care (POC) Diagnostic Devices Demand Share, 2019-2026
13. Middle East & Africa Point of Care (POC) Diagnostic Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Application
13.4.1. Patient Self-Testing
13.4.2. Clinics
13.4.3. Hospitals
13.4.4. Laboratories
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Point of Care (POC) Diagnostic Devices Market Size and Volume Forecast by Type
13.7.1. Miniaturization and Microfluidics Technology
13.7.2. Molecular Diagnostics
13.7.3. Non-Invasive Technology
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Point of Care (POC) Diagnostic Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Point of Care (POC) Diagnostic Devices Market: Market Share Analysis
14.2. Point of Care (POC) Diagnostic Devices Distributors and Customers
14.3. Point of Care (POC) Diagnostic Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abaxis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott POC
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Alere Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Beckman Coulter
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckton & Dickinson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bayer Diabetes Care
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hemocue AB
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. International Technidyne Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. LifeScan Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nipro Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Orasure Technologies
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PointCare Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Siemens HealthCare Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
